Summary
Cardinal Health, Inc. (CAH) has filed an 8-K report detailing a civil settlement with the Attorney General's Office of the State of New York (NYAG) concerning an investigation into secondary market pharmaceutical trading. The company, without admitting or denying findings, has agreed to pay a total of $11.0 million. This amount includes $3.0 million to the State of New York, $1.0 million for investigation costs, and $7.0 million to a not-for-profit entity supporting New York State health initiatives. Importantly, Cardinal Health had previously established reserves for the full $11.0 million settlement amount, indicating this financial impact was anticipated. The company has also committed to implementing business reforms within its pharmaceutical distribution segment as part of the settlement. While the settlement aims to resolve the investigation, the company acknowledges that it could still face adverse effects from existing litigation, future proceedings, or negative publicity.
Key Highlights
- 1Cardinal Health entered into a civil settlement with the New York Attorney General's Office (NYAG) on December 26, 2006.
- 2The settlement resolves an investigation into the secondary market for pharmaceuticals.
- 3The company will pay a total of $11.0 million: $3.0 million to the State of New York, $1.0 million for investigation costs, and $7.0 million to a New York-affiliated not-for-profit.
- 4Cardinal Health does not admit or deny the NYAG's findings as part of the settlement.
- 5The company had previously recorded reserves for the full $11.0 million settlement amount, suggesting no new unexpected financial charge.
- 6Cardinal Health will implement business reforms within its pharmaceutical distribution business as required by the settlement.
- 7The company notes that the settlement may not prevent adverse impacts from existing litigation, future proceedings, or negative publicity.